SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay a who wrote (795)5/4/1997 6:47:00 PM
From: I. Luttichuys   of 1762
 
If I am the only one out on the east coast, anyone interested in a report so's you can know what the general tone was before it's been all over the place? :o)
I have a question for anyone out there who may know this. I am studying for a Neuro final so I cannot spend time looking this up myself. Has anyone heard whether IDEC C2B8 has been discussed with respect to treating HIV related NHL? I was speaking today to an AIDS oncologist in San Francisco with whom I will be working this summer and he seemed quite interested in C2B8 but, I was unable to answer this question difinitively for him. Interestingly enough, he recently caused something of a stir when he presented some of his own research on the psycho-social aspects and quality of life issues related to AIDS related NHL therapies currently in the armamentarium. It seems that no research has been done on this with docs focusing almost exclusively on tumour mass reductions and patients focusing on quality of life issues not so much caring about a centimetre here or there when their quality of life is compromised by therapy. Judging by the reaction his study received, it would seem that there is great interest and emphasis coming to be placed on therapies which address for patients and their physicians, the quality of life issue as it concerns achieving some sort of balance with clinical results.
I cannot imagine a better time for IDEC C2B8 to be coming to market and to greater public awareness.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News